Search
The pharmaceutical industry faces a challenging business environment as competition drives down prices, R&D expenses rise, and government scrutiny deepens. However, companies have many options for navigating these challenges, generally by making deals with others in the field, including mergers and...
![Michelle C. Streifthau-Livizos](/sites/default/files/styles/card_410x307_/public/images/2022-08/Streifthau-Livizos_Michelle_LinkedIn.jpg?h=7126a54b&itok=zKkPFFZM)
Michelle Streifthau-Livizos represents clients in litigation matters, including disputes involving the Hatch-Waxman Act, patents, copyrights and trademarks. She handles cases involving various types of technology, including representations of pharmaceutical companies, life sciences companies...
![Sarah A. Sullivan](/sites/default/files/styles/card_410x307_/public/images/2022-08/Sullivan_Sarah_LinkedIn.jpg?h=f57dba4b&itok=WTcmsQKD)
Sarah Sullivan represents pharmaceutical companies involved in complex, high stakes patent litigation. Sarah concentrates her practice on Hatch-Waxman ANDA cases and disputes over the intellectual property behind branded pharmaceuticals. She is part of the Firm's nationally-recognized team for...
Saul Ewing’s experienced patent attorneys assist companies and institutions in securing, leveraging, and enforcing commercially valuable intellectual property. From developing patent strategies on a global scale to vigorously asserting and defending patents in court, our team serves as trusted...
![Charles M. Lizza](/sites/default/files/styles/card_410x307_/public/images/2022-08/Lizza_Charles_LinkedIn.jpg?h=e88f149d&itok=6qVOhWnJ)
Charlie Lizza brings more than 40 years of litigation experience to his representation of pharmaceutical companies in high stakes patent litigation. Mr. Lizza concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical and medical...
![Alexander Callo](/sites/default/files/styles/card_410x307_/public/images/2022-10/Callo_Alexander_LinkedIn.jpg?h=915cd633&itok=kOUVHrIi)
Alex Callo represents clients in high stakes intellectual property litigation, with a specific focus on complex pharmaceutical patent litigation under the Hatch-Waxman Act. His experience includes drafting motions and pleadings, research, and analyzing discovery. Alex has a background in both...
![William Baton's Headshot](/sites/default/files/styles/card_410x307_/public/images/2022-08/Baton_William_LinkedIn.jpg?h=40c24adf&itok=K65MBbuy)
Bill Baton represents pharmaceutical companies in complex, often high-profile, patent litigation. Bill concentrates his practice in Hatch-Waxman ANDA litigation and protecting the intellectual property of branded pharmaceutical companies. He currently serves as New Jersey litigation counsel in more...
![Robert C. Gill](/sites/default/files/styles/card_410x307_/public/images/2022-08/Gill_Robert_LinkedIn.jpg?h=40c24adf&itok=WaDgveuP)
Robert Gill has more than 35 years of experience as a commercial litigator. Robert handles cases both locally in the Washington, D.C. metro area and throughout the United States, and has tried a number of cases in state and federal courts, and before arbitration tribunals. He has particular...